Form 4 for HCA HCA Healthcare
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001209191-23-006031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-01 | 2023-02-01 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale | $257.11 | -4,000 | 20.8K | -16% | -$1.03M |
| D | 2023-02-01 | 2022-10-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | G - Gift | $0.00 | -450 | 24.8K | -2% | $0 |
| D | 2023-02-01 | 2023-01-30 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | A - Grant | $0.00 | +14.5K | 14.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | S | D | 4,000 | $257.11 | 20,822.55 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.1031 to $257.285, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F1) Includes 2,330.5543 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2022-10-31 | G | D | 450 | $0.00 | 24,822.55 | D | — | — | (F1) Includes 2,330.5543 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 3 | Derivative | Stock Appreciation Right | 2023-01-30 | A | A | 14,524 | $0.00 | 14,524 | D | $253.30 · 2024-01-30 to 2033-01-30 | 14,524 Common Stock | (F3) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. |